SBIR/STTR Research Award
DEVELOPMENT OF NEW ASSAYS OF MAST CELLS SECRETION
Award amount
$93,363Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PROTEIN SYSTEMS
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION: Novel assays will be developed to provide reliable measurement of
released mast cell proteases as alternatives to histamine-release assays to
detect mast cell secretion. The research will evaluate synthetic substrates
such as peptide 4-nitroanilides for use in calorimetric assays. Routine assays
for histamine are tedious, slow, prone to error and relatively insensitive. The
primary goal of the proposed research is to test the feasibility that the
protease assays offer clear advantages compared to histamine-release assays.
The protease assays are expected to be rapid, sensitive and adaptable to high
throughput detection of mast cell secretion that will be useful to screen large
numbers of compounds potentially acting on mast cells. Additionally, the assays
will have utility in identifying drugs that lead to mast cell-mediated
toxicity. The new assays will be used to study mast cells that produce low
levels of histamine. The availability of the improved assays may stimulate mast
cell research.
PROPOSED COMMERCIAL APPLICATION:
The ability to produce many compounds by combinatorial chemistry requires high
throughput screening assays to facilitate drug discovery. New assays will permit
a rapid assessment of drug candidates targeting mast cells and provide early
information of potential mast cell-mediated toxicity. A screening service of this type
may be of considerable commercial benefit to drug companies.
Technology keywords
Not reported